Blood Lancet

Blood Lancet Market Outlook

The global blood lancet market is projected to reach approximately USD 1.5 billion by 2033, with a compound annual growth rate (CAGR) of 6.5% from 2025 to 2033. This growth trajectory is primarily driven by the rising prevalence of diabetes and other chronic diseases requiring regular blood testing, as well as the increasing demand for home healthcare services. Furthermore, advancements in lancet technology, such as the development of safety lancets and pressure-activated devices, enhance user convenience and safety, consequently propelling market growth. Increasing awareness and availability of blood testing devices, combined with the expansion of diagnostic centers, are also significant contributors to the market's expansion. Enhanced healthcare infrastructure and rising disposable incomes in emerging economies further bolster the market's potential.

Growth Factor of the Market

The blood lancet market is driven by multiple growth factors that are shaping the industry's future landscape. First and foremost, the growing global prevalence of diabetes necessitates frequent blood sugar monitoring, creating a demand for efficient and user-friendly blood lancet devices. Additionally, the aging population is more susceptible to various health conditions that require regular monitoring, thus increasing the adoption of these devices. Technological advancements, particularly the introduction of safety lancets designed to minimize the risk of needle-stick injuries, are gaining traction among healthcare professionals and patients alike. Furthermore, the rise of telemedicine and remote patient monitoring is steering the focus towards homecare settings, where blood lancets play a crucial role in self-testing. Lastly, the increasing need for preventive healthcare measures highlights the importance of blood testing for timely diagnosis and management of health conditions, further propelling the market forward.

Key Highlights of the Market

• Rapidly growing demand for diabetes management tools.
• Technological advancements in lancet design ensuring user safety.
• Increasing prevalence of chronic diseases requiring blood testing.
• Expanding homecare settings contributing to market growth.
• Rising awareness of preventive healthcare measures.

By Product Type

Safety Lancets:

Safety lancets are designed primarily to reduce the risk of needle-stick injuries, making them a popular choice for both healthcare professionals and individuals managing their health at home. These devices feature a retractable needle system that automatically withdraws the needle after use, ensuring enhanced safety and reducing the likelihood of accidental punctures. The rising awareness of safety, especially in blood testing, has led to increased adoption of safety lancets in various settings, including hospitals, clinics, and homecare environments. Furthermore, healthcare regulations emphasizing the importance of safety in medical devices are propelling the demand for these innovative products. As a result, safety lancets are expected to experience significant growth in the coming years, owing to their practicality and user-friendly features.

Standard Lancets:

Standard lancets have been widely used in blood sampling for years and are characterized by their affordability and ease of use. These lancets typically consist of a simple needle housed in a plastic casing which, while effective, do not offer the same safety features as their counterparts. Nevertheless, the accessibility and cost-effectiveness of standard lancets continue to appeal to a large segment of the population, particularly in developing regions where healthcare expenditures may be limited. Moreover, despite the emergence of more advanced options, standard lancets remain an essential component of many blood testing kits, ensuring a steady demand in various healthcare settings.

Pediatric Lancets:

Pediatric lancets are specifically designed for infants and children, addressing the unique requirements of blood sampling in younger patients. These lancets often feature smaller gauge needles to minimize pain and discomfort during testing. Their design is geared towards ensuring that parents and healthcare providers can conduct blood tests with minimal distress to the child. The growing emphasis on early detection and management of diseases among children is driving the demand for pediatric lancets. With the increasing focus on preventative healthcare in pediatrics, the need for effective blood sampling solutions tailored to younger populations has never been more critical, resulting in a promising growth outlook for this segment.

Pressure-Activated Lancets:

Pressure-activated lancets utilize a unique mechanism that requires a certain amount of pressure to activate the needle, enabling a more controlled and precise blood sampling process. This feature not only enhances safety but also reduces the risk of over-penetration, making them suitable for both professional and homecare settings. The growing preference for devices that offer better control and safety features is bolstering the popularity of pressure-activated lancets among healthcare providers. As patients become increasingly involved in managing their health, the demand for user-friendly and reliable blood sampling devices such as pressure-activated lancets is projected to rise significantly.

Blade Lancets:

Blade lancets, which employ a small blade for blood sampling, are often used in specific clinical settings for more extensive blood testing. Their design allows for a larger blood sample, making them suitable for tests that require more than just a drop of blood. While less common than other types of lancets, blade lancets play a vital role in specialized healthcare applications. The continued implementation of advanced blood testing technologies and the need for larger samples in certain diagnostic tests are expected to sustain demand for blade lancets. Furthermore, the versatility of blade lancets in various medical scenarios can help to maintain their relevance in the broader blood lancet market.

By Application

Glucose Testing:

Glucose testing is one of the primary applications driving the demand for blood lancets, particularly among individuals with diabetes. Regular glucose monitoring is essential for effective diabetes management, enabling patients to adjust their diet and medication accordingly. The convenience of home glucose testing has led to a proliferation of blood lancets specifically designed for this purpose. The growing prevalence of diabetes worldwide, estimated to affect approximately 537 million adults as of 2021, underscores the increasing demand for glucose testing devices. Consequently, the glucose testing segment is expected to witness sustained growth, further propelled by advancements in testing technologies that enhance accuracy and user convenience.

Hemoglobin Testing:

Hemoglobin testing plays a critical role in diagnosing various health conditions, including anemia and blood disorders. Blood lancets are essential in obtaining the necessary blood samples for hemoglobin testing, which is often performed in both clinical and home settings. With the rising incidence of anemia and other blood-related disorders, the demand for hemoglobin testing is steadily increasing. Furthermore, advancements in portable hemoglobin testing devices that utilize blood lancets are making it easier for individuals to monitor their hemoglobin levels conveniently and accurately. This segment is poised for growth as the healthcare industry continues to prioritize timely diagnosis and intervention.

Cholesterol Testing:

Cholesterol testing is another significant application of blood lancets, utilized extensively in both clinical and home testing environments. Regular monitoring of cholesterol levels is essential for individuals at risk of cardiovascular diseases, making blood lancets an indispensable tool in preventive healthcare. The growing awareness of heart health and the importance of routine cholesterol testing are driving demand in this segment. As more individuals seek to take control of their health through self-testing, cholesterol testing with blood lancets is expected to gain traction, contributing to the overall growth of the blood lancet market.

Coagulation Testing:

Coagulation testing is crucial for individuals with blood clotting disorders, ensuring proper management and intervention as needed. Blood lancets are essential for obtaining samples for various coagulation tests, which can often be performed at home or in outpatient settings. The increasing prevalence of conditions such as atrial fibrillation and deep vein thrombosis is driving demand for coagulation testing, thereby boosting the need for blood lancets. With a focus on improving patient outcomes and reducing hospital visits, the coagulation testing segment is likely to experience significant growth as more healthcare providers and patients embrace home testing solutions.

Other Blood Tests:

In addition to the primary applications mentioned above, blood lancets are also used in a variety of other blood tests, including infectious disease screening and metabolic panels. This diverse application range contributes to the overall demand for blood lancets, as healthcare providers increasingly adopt point-of-care testing solutions to enhance diagnostic capabilities. The rising emphasis on preventive healthcare and rapid testing methodologies further supports this segment's growth. As healthcare continues to evolve towards more efficient and patient-centered models, the significance of blood lancets in various diagnostic applications cannot be overstated.

By Distribution Channel

Hospitals:

The hospital segment remains a significant distribution channel for blood lancets, characterized by high volume usage in various healthcare services. Blood lancets are widely utilized in hospitals for routine blood tests, emergency care, and specialized medical procedures. Hospitals prioritize the adoption of safety lancets and other innovations to minimize risk and enhance patient care. Additionally, hospitals are increasingly investing in advanced diagnostic technologies, further driving demand for blood lancets. The growing focus on improving patient safety and optimizing operational efficiencies in hospitals is expected to contribute to sustained growth in this distribution channel.

Clinics:

Clinics, including primary care and specialized medical practices, represent another important distribution channel for blood lancets. The demand for blood testing and monitoring in outpatient settings drives clinic purchases of lancets, which are essential for patient assessments and routine check-ups. The emphasis on preventive care and early disease detection is encouraging clinics to maintain readily available blood testing supplies, including lancets. As more clinics adopt patient-centered care models and integrate technology into their operations, the demand for blood lancets is projected to continue growing robustly in this segment.

Homecare Settings:

Homecare settings have become a rapidly growing distribution channel for blood lancets, driven by the increasing number of patients managing chronic conditions at home. The convenience and comfort of self-testing have led to a surge in the adoption of blood lancets in homecare environments. Patients with diabetes, cardiovascular diseases, and other health conditions are increasingly utilizing blood lancets for regular monitoring and management. The expansion of telehealth services and remote patient monitoring solutions further encourages the use of blood lancets in homecare settings. As the healthcare industry continues to embrace patient empowerment, the homecare segment is poised for significant growth.

Diagnostic Centers:

Diagnostic centers are critical distribution channels for blood lancets, providing a wide range of testing services essential for accurate diagnosis and treatment planning. These centers utilize blood lancets extensively for various blood tests, including glucose, cholesterol, and hemoglobin testing. The growing number of diagnostic centers globally, particularly in urban areas, is contributing to increased demand for blood lancets. As more individuals seek timely and accurate diagnostic services, the reliance on diagnostic centers for blood testing will further drive the need for these essential tools. The emphasis on rapid and reliable testing solutions positions diagnostic centers as a key player in the blood lancet market.

By Material Type

Stainless Steel Lancets:

Stainless steel lancets are highly favored in the blood lancet market due to their durability, sharpness, and biocompatibility. The use of stainless steel ensures that the needles are strong enough to penetrate the skin effectively while minimizing pain during the sampling process. These lancets are widely utilized in clinical settings and by individuals for home testing, owing to their effectiveness and safety. The demand for stainless steel lancets is expected to grow as healthcare providers prioritize high-quality materials that enhance patient comfort and reduce the risk of complications. Additionally, stainless steel's resistance to corrosion and wear makes it a preferred choice among manufacturers and users alike.

Plastic Lancets:

Plastic lancets offer a cost-effective alternative to stainless steel options, appealing to budget-conscious consumers and healthcare providers. They are lightweight and designed for single-use, ensuring convenience and safety. While plastic lancets may not offer the same level of sharpness as stainless steel, they are widely used for basic blood testing in homecare settings and by patients requiring frequent monitoring. The growth of home healthcare services and the increasing number of self-testing devices are contributing to the demand for plastic lancets. As consumers seek affordable yet effective blood sampling solutions, plastic lancets are expected to maintain a steady share of the market.

Silicon-coated Lancets:

Silicon-coated lancets are designed with a thin layer of silicone that enhances the lancet's ability to penetrate the skin with minimal discomfort. This innovation is particularly appealing to individuals who may experience anxiety or pain during blood testing. The coating reduces friction and ensures a smoother insertion process, making silicon-coated lancets a popular choice among patients, especially in pediatric applications. As the awareness of pain management in medical procedures continues to grow, the adoption of silicon-coated lancets is likely to increase, further diversifying the blood lancet market.

Glass Lancets:

Glass lancets, while less common than other types, are utilized in specific medical applications that require precise blood sampling. They are often employed in laboratory settings for specialized tests where sample integrity is critical. The durability and easy sterilization of glass lancets make them suitable for repeated use in controlled environments. However, their adoption in general healthcare settings is limited due to concerns over safety and breakage. As a result, glass lancets occupy a niche segment within the broader blood lancet market, primarily serving specialized diagnostic needs.

Others:

The "Others" category encompasses various innovative blood lancet designs and materials that do not fit into the primary classifications. This segment may include advanced lancets with integrated technology for painless sampling, wireless connectivity for data transmission, and unique materials aimed at enhancing user experience. The increasing focus on technological advancements in healthcare is expected to propel growth in this segment, as manufacturers seek to meet the evolving demands of consumers and healthcare providers. As healthcare becomes more technology-driven, the innovation in blood lancet design will play a significant role in shaping the market's future.

By Region

The North American blood lancet market is expected to dominate, driven by the high prevalence of diabetes and advanced healthcare infrastructure. The region is projected to hold a significant market share, estimated at approximately 40% of the global market by 2033. The increasing emphasis on preventive healthcare, coupled with a rising number of diabetic patients, contributes to the demand for blood lancets in this region. Furthermore, technological advancements and the integration of telehealth solutions are enhancing the accessibility of blood testing devices, further propelling market growth in North America. With a CAGR of around 5.8%, the North American blood lancet market is poised for steady growth in the coming years.

In Europe, the blood lancet market is also experiencing substantial growth, attributed to the increasing focus on healthcare quality and innovation. The European market is expected to account for around 30% of the global share, with a growing preference for safety lancets and advanced testing devices. The prevalence of chronic diseases and the aging population in Europe are driving demand for routine blood testing solutions. Additionally, supportive government initiatives aimed at enhancing healthcare access and improving patient outcomes are likely to sustain growth in this region. As the market evolves, manufacturers are expected to focus on developing user-friendly and safe blood lancet designs to cater to the diverse needs of European consumers.

Opportunities

The blood lancet market presents numerous opportunities driven by several trends and market dynamics. One significant opportunity lies in the increasing adoption of telehealth and remote monitoring solutions, particularly in the wake of the COVID-19 pandemic, which has accelerated the shift towards at-home healthcare. As more patients opt for remote blood testing and monitoring, the demand for convenient and user-friendly blood lancets is expected to rise. Manufacturers who can innovate and develop products that cater to this need—such as lancets compatible with point-of-care testing devices—will likely gain a competitive advantage in the market. Furthermore, educational campaigns aimed at raising awareness about chronic diseases and the importance of regular testing can stimulate demand for blood lancets across various demographics, presenting an avenue for market growth.

Another opportunity lies in the growing emphasis on personalized healthcare and preventative medicine. As patients increasingly seek to monitor their health and manage chronic conditions proactively, the demand for blood testing devices—including blood lancets—will continue to rise. The trend towards integrating technology into healthcare, such as the development of smart lancets that connect to mobile applications for tracking and data analysis, is an area ripe for innovation. Companies that invest in research and development to create advanced blood lancet solutions that cater to these emerging trends will be well-positioned to capitalize on the expanding opportunities within the market in the coming years.

Threats

Despite the lucrative growth potential, the blood lancet market faces several threats that could hinder its expansion. One of the primary threats is the increasing competition from alternative blood testing methods, such as non-invasive monitoring technologies that eliminate the need for skin punctures altogether. As advancements in technology continue to emerge, consumers may gravitate towards these innovative solutions, posing a challenge for traditional blood lancets. Additionally, price sensitivity in certain market segments, particularly in developing regions, may result in challenges for manufacturers aiming to maintain profitability while offering competitive pricing. The threat of stringent regulatory requirements could also impact the speed to market for new products, potentially limiting innovation and market entry for emerging players.

Furthermore, the growing concern over needle-stick injuries and the associated risks could lead to heightened scrutiny over the safety of traditional blood lancets. If manufacturers fail to prioritize safety features in product development, they may encounter backlash from both consumers and regulatory bodies, which could ultimately hurt their market position. Lastly, fluctuations in raw material prices, such as stainless steel and plastics used in production, can impact manufacturing costs and profit margins for companies within the blood lancet market. Addressing these threats will be crucial for market participants aiming to sustain growth and maintain their competitive edge.

Competitor Outlook

• Abbott Laboratories
• Thermo Fisher Scientific
• Becton, Dickinson and Company (BD)
• Roche Diagnostics
• Accu-Chek (Roche)
• GlucoRx
• Sanofi
• Beurer GmbH
• Ascensia Diabetes Care
• HemoCue AB
• Medtronic
• Quest Diagnostics
• LifeScan, Inc.
• Sysmex Corporation
• Arkray, Inc.

The competitive landscape of the blood lancet market is characterized by the presence of several established players, each vying for market share through innovation, product differentiation, and strategic collaborations. Companies like Abbott Laboratories and Becton, Dickinson and Company (BD) are prominent leaders, leveraging their expertise in medical devices and extensive distribution networks to capture a significant portion of the market. These companies continuously invest in research and development efforts to enhance their product offerings, focusing on safety and user convenience in blood lancet design. Additionally, they engage in partnerships with healthcare providers and organizations to promote their products and expand market reach, further solidifying their positions as market leaders.

Emerging players, such as GlucoRx and Ascensia Diabetes Care, are also gaining traction in the blood lancet market by targeting specific segments such as homecare settings and diabetes management solutions. These companies prioritize affordability and accessibility in their product offerings, catering to the growing number of patients seeking effective blood testing solutions at home. Their strategies involve leveraging technological advancements to develop user-friendly devices that resonate with the preferences of modern consumers. The competitive environment remains dynamic, with ongoing innovations and the entry of new players creating a landscape ripe for transformation.

As companies navigate the competitive landscape, it is essential to pay attention to key competitors like Roche Diagnostics and Thermo Fisher Scientific, which are known for their robust portfolios in diagnostic solutions, including blood testing. These companies not only focus on blood lancets but also offer comprehensive testing systems that incorporate advanced technologies for precise results. Their established reputations and strong brand recognition position them as formidable competitors in the market. Additionally, strategic mergers and acquisitions among key players can lead to enhanced market capabilities, further intensifying competition and shaping the future of the blood lancet market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Sanofi
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 GlucoRx
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Medtronic
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 HemoCue AB
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Beurer GmbH
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Arkray, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 LifeScan, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Accu-Chek (Roche)
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Quest Diagnostics
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Roche Diagnostics
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Sysmex Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Abbott Laboratories
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Ascensia Diabetes Care
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Thermo Fisher Scientific
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Becton, Dickinson and Company (BD)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Blood Lancet Market, By Application
    • 6.1.1 Glucose Testing
    • 6.1.2 Hemoglobin Testing
    • 6.1.3 Cholesterol Testing
    • 6.1.4 Coagulation Testing
    • 6.1.5 Other Blood Tests
  • 6.2 Blood Lancet Market, By Product Type
    • 6.2.1 Safety Lancets
    • 6.2.2 Standard Lancets
    • 6.2.3 Pediatric Lancets
    • 6.2.4 Pressure-Activated Lancets
    • 6.2.5 Blade Lancets
  • 6.3 Blood Lancet Market, By Material Type
    • 6.3.1 Stainless Steel Lancets
    • 6.3.2 Plastic Lancets
    • 6.3.3 Silicon-coated Lancets
    • 6.3.4 Glass Lancets
    • 6.3.5 Others
  • 6.4 Blood Lancet Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Clinics
    • 6.4.3 Homecare Settings
    • 6.4.4 Diagnostic Centers

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Blood Lancet Market by Region
  • 10.3 Asia Pacific - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 India
      • 10.3.1.2 China
      • 10.3.1.3 Japan
      • 10.3.1.4 South Korea
  • 10.4 Latin America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 Brazil
      • 10.4.1.2 Argentina
      • 10.4.1.3 Mexico
  • 10.5 North America - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 USA
      • 10.5.1.2 Canada
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Blood Lancet market is categorized based on

By Product Type

• Safety Lancets
• Standard Lancets
• Pediatric Lancets
• Pressure-Activated Lancets
• Blade Lancets

By Application

• Glucose Testing
• Hemoglobin Testing
• Cholesterol Testing
• Coagulation Testing
• Other Blood Tests

By Distribution Channel

• Hospitals
• Clinics
• Homecare Settings
• Diagnostic Centers

By Material Type

• Stainless Steel Lancets
• Plastic Lancets
• Silicon-coated Lancets
• Glass Lancets
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Abbott Laboratories
• Thermo Fisher Scientific
• Becton, Dickinson and Company (BD)
• Roche Diagnostics
• Accu-Chek (Roche)
• GlucoRx
• Sanofi
• Beurer GmbH
• Ascensia Diabetes Care
• HemoCue AB
• Medtronic
• Quest Diagnostics
• LifeScan, Inc.
• Sysmex Corporation
• Arkray, Inc.